Direct oral anticoagulants in asian patients with atrial fibrillation: Consensus recommendations by the Asian Pacific Society of Cardiology on strategies for thrombotic and bleeding risk management

Daniel T.T. Chong, Felicita Andreotti, Peter Verhamme, Jamshed J. Dalal, Noppacharn Uaprasert, Chun Chieh Wang, Young Keun On, Yi Heng Li, Jun Jiang, Koji Hasegawa, Khalid Almuti, Rong Bai, Sidney T.H. Lo, Rungroj Krittayaphong, Lai Heng Lee, David K.L. Quek, Sofian Johar, Swee Chong Seow, Christopher J. Hammett, Jack W.C. Tan

研究成果: Article同行評審

3 引文 斯高帕斯(Scopus)

摘要

The disease burden of AF is greater in Asia-Pacific than other areas of the world. Direct oral anticoagulants (DOACs) have emerged as effective alternatives to vitamin K antagonists (VKA) for preventing thromboembolic events in patients with AF. The Asian Pacific Society of Cardiology developed this consensus statement to guide physicians in the management of AF in Asian populations. Statements were developed by an expert consensus panel who reviewed the available data from patients in Asia-Pacific. Consensus statements were developed then put to an online vote. The resulting 17 statements provide guidance on the assessment of stroke risk of AF patients in the region, the appropriate use of DOACs in these patients, as well as the concomitant use of DOACs and antiplatelets, and the transition to DOACs from VKAs and vice versa. The periprocedural management of patients on DOAC therapy and the management of patients with bleeding while on DOACs are also discussed.

原文English
文章編號e23
期刊European Cardiology Review
16
DOIs
出版狀態Published - 2021

All Science Journal Classification (ASJC) codes

  • 心臟病學與心血管醫學

指紋

深入研究「Direct oral anticoagulants in asian patients with atrial fibrillation: Consensus recommendations by the Asian Pacific Society of Cardiology on strategies for thrombotic and bleeding risk management」主題。共同形成了獨特的指紋。

引用此